Evidence map›Paper›PMID 29305797›Full record

ArticleJournal of the American Society for Mass Spectrometry2018

Anatomical-Molecular Distribution of EphrinA1 in Infarcted Mouse Heart Using MALDI Mass Spectrometry Imaging.

Stephan Lefcoski, Kimberly Kew, Shaun Reece, Maria J Torres, Justin Parks, Sky Reece, Lisandra E de Castro Brás, Jitka A I Virag

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Trends in mass spectrometry imaging for cardiovascular diseases.Analytical and bioanalytical chemistry · 2019
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Stephan LefcoskiDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA.
Kimberly KewDepartment of Chemistry, East Carolina University, Greenville, NC, 27834, USA.
Shaun ReeceDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA.
Maria J TorresEast Carolina Diabetes and Obesity Institute, East Carolina University, Greenville, NC, 27834, USA.
Justin ParksDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA.
Sky ReeceDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA.
Lisandra E de Castro BrásDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA.
Jitka A I ViragDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, NC, 27834, USA. viragj@ecu.edu.
East Carolina University · US

Funding

Salvaging the ischemic myocardium: the role ephrinA1/EphA bidirectional signalingR15HL124483 · NHLBI · EAST CAROLINA UNIVERSITY · PI VIRAG, JITKA A.I. · 2015 to 2015
$443k
American Heart Association 14SDG18860050NHLBI NIH HHS R15 HL124483NIH HHS HL124483
6 · The paper itself

Abstract

EphrinA1 is a tyrosine kinase receptor localized in the cellular membrane of healthy cardiomyocytes, the expression of which is lost upon myocardial infarction (MI). Intra-cardiac injection of the recombinant form of ephrinA1 (ephrinA1-Fc) at the time of ligation in mice has shown beneficial effects by reducing infarct size and myocardial necrosis post-MI. To date, immunohistochemistry and Western blotting comprise the only experimental approaches utilized to localize and quantify relative changes of ephrinA1 in sections and homogenates of whole left ventricle, respectively. Herein, we used matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI) coupled with a time-of-flight mass spectrometer (MALDI/TOF MS) to identify intact as well as tryptic fragments of ephrinA1 in healthy controls and acutely infarcted murine hearts. The purpose of the present study was 3-fold: (1) to spatially resolve the molecular distribution of endogenous ephrinA1, (2) to determine the anatomical expression profile of endogenous ephrinA1 after acute MI, and (3) to identify molecular targets of ephrinA1-Fc action post-MI. The tryptic fragments detected were identified as the ephrinA1-isoform with 38% and 34% sequence coverage and Mascot scores of 25 for the control and MI hearts, respectively. By using MALDI-MSI, we have been able to simultaneously measure the distribution and spatial localization of ephrinA1, as well as additional cardiac proteins, thus offering valuable information for the elucidation of molecular partners, mediators, and targets of ephrinA1 action in cardiac muscle. Graphical Abstract ᅟ.

Indexed as

Amino Acid SequenceAnimalsEphrin-A1MaleMiceMyocardial InfarctionMyocardiumSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationEphrin-A1EphrinA1MALDI/IMSMyocardial infarction

Identifiers

PMID29305797
PMCPMC5838209
OpenAlexW2781791832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.